Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Safety Study of PLX4032 in Patients With Solid Tumors

NCT00405587

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +20 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

NCT00045110

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +28 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

NCT00980343

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma

NCT00727506

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • 1200.36.0016 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1200.36.0012 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1200.36.0005 Boehringer Ingelheim Investigational Site Duarte, California, United States
  • 1200.36.0014 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 28 locations
View Trial Details
Completed

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

NCT01001299

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • UCLA - School of Medicine Los Angeles, California, United States
  • Massachusetts General Hospital;Hematology/ Oncology Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Ctr Nashville, Tennessee, United States
View Trial Details
Completed

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

NCT00521001

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • St. Anthony Central Hospital Denver, Colorado, United States
View all 198 locations
View Trial Details
Completed

A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)

NCT01708174

Conditions
Disease Attributes, Glioma, Medulloblastoma, +11 more
Locations
  • Ann & Robert H. Lurie Children Dept of Oncology Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Dept Onc Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Dept of Oncology New York, United States
View all 41 locations
View Trial Details

Related conditions